New EMA Filings: Speedy Review For Lanadelumab But Cemiplimab Gets Standard Treatment

 
• By Maureen Kenny
  
torn paper revealing the phrase "what's new?"
The EMA will shortly reveal which new products have been filed for approval • Source: Shutterstock

More from Europe

More from Geography